Patent · US Expired

Chemotherapeutic antineoplastic treatment

US7671040B2 · kind B2 · utility

0Cited by
2References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2003
Grant dateMar 2, 2010
Priority date
Expiry dateNov 2, 2024

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Chemotherapeutic antineoplastic method comprising administration of an effective amount of an antineoplastic agent in conjunction with an effective amount of a β-1,3 glucan.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.